Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis-Reference-Cited by-同舟云学术

Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis

Published:2022-11-15 Issue:5 Volume:57 Page:486-495
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Cortesi Paolo Angelo¹^ORCID,Fiorino Gionata²^ORCID,Peyrin‐Biroulet Laurent³^ORCID,Mantovani Lorenzo Giovanni¹⁴^ORCID,Jairath Vipul⁵^ORCID,Paridaens Kristine⁶^ORCID,Andersson Fredrik L.⁷,Danese Silvio²^ORCID

Affiliation:

1. Research Centre on Public Health (CESP) University of Milano‐Bicocca Monza Italy

2. Department of Gastroenterology and Digestive Endoscopy IRCCS San Raffaele Hospital and Vita‐Salute San Raffaele University Milan Italy

3. Department of Gastroenterology and Inserm NGERE U1256 Nancy University Hospital, University of Lorraine Vandoeuvre‐lès‐Nancy France

4. IRCCS, Istituto Auxologico Italiano Milan Italy

5. Department of Medicine, Division of Gastroenterology Western University London Ontario Canada

6. Ferring International Center Saint‐Prex Switzerland

7. Ferring Pharmaceuticals A/S – International PharmaScience Center Kastrup Denmark

Funder

Ferring

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17261

Reference26 articles.

1. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

2. Etiology of inflammatory bowel disease: A unified hypothesis

3. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

4. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

5. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence: a new tool in the pathologist's armamentarium for the diagnosis of IBD;Computational and Structural Biotechnology Journal;2024-09

2. Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis—The OPTIMISE Study;Journal of Clinical Medicine;2024-08-30

3. Practical management of mild-to-moderate ulcerative colitis: an international expert consensus;Expert Review of Gastroenterology & Hepatology;2024-08-02

4. Drug Optimization in Patients with Mild-to-Moderate Ulcerative Colitis: A Global Survey;Journal of Clinical Medicine;2024-04-24

5. Construction of a molecular inflammatory predictive model with histone modification-related genes and identification of CAMK2D as a potential response signature to infliximab in ulcerative colitis;Frontiers in Immunology;2024-01-11